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ABSTRACT Two electrode voltage clamp conditions were used to study the early effects on ionic membrane channels of the
intracellularly injected proto-oncogenic form of c-Ha-ras (c-ras) and its oncogenic counterpart v-Ha-ras (v-ras). These
experiments were conducted on isolated somata of identified fully differentiated neurons of the sea snail Hermissenda. 20
min after c-ras, and 10 min after v-ras intracellular injections into type B medial photoreceptors of Hermissenda, the peak
amplitude of two outward potassium currents (/A and /c), across the isolated Type B soma membrane begin to decrease.
These two currents have been previously isolated by differences in activation and inactivation kinetics and their response to
pharmacological blockers. c- or v-ras injections did not have any effect on a voltage-dependent inward calcium current.
Reduction of /A preceded that of /c Current reductions due to c-ras, but not to v-ras injection reversed spontaneously after
40 min. The voltage dependence of the steady state inactivation of /A shifted toward more negative potentials with ras
injections. Ras-mediated cell transformations therefore, could involve, perhaps as initial events, prolonged modification of
membrane currents.
INTRODUCTION
Ras gene products are a large family of 21 Kd proteins,
widely distributed across species that have an essential,
but as yet poorly characterized, cellular function (1-3).
Because of their binding of guanine nucleotides and
GTPase activity, they have been classified as G proteins
(4). A cytosolic co-factor modulates ras activation and
inactivation upon interaction with unknown plasma mem-
brane target(s)(5). Mutating forms of ras have reduced
GTPase activity and resistance to modulation by a cyto-
plasmic co-factor, the GTPase activating protein (GAP).
Such forms may cause irreversible activation of biochem-
ical pathways that control cell growth and development
and that eventually lead to oncogenic transformation.
Microinjections of ras have been shown to induce cell
growth (6), pinocytosis, and membrane ruffling (7). The
earliest effect reported so far of ras injection is a rapid
increase in pH within 10 min of v-ras but not c-ras
injections. This effect was attributed to an increase in the
Na/H antiporter (8). Phosphoinositide metabolism was
initially postulated as a ras target (3), but recent studies
(9-11) have suggested nonspecific changes secondary to
all oncogenic transformations.
We have previously isolated and characterized a 20-Kd
G protein (12) which undergoes increased protein kinase
C-mediated phosphorylation during long-term storage of
an associative memory. This G protein also regulates
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axonal transport (13) as well as reduces K+ currents. It,
therefore, could be responsible for profound memory-
specific cellular transformations such as the recently
observed structural changes of neuronal terminal branches
(14). The present report was undertaken to examine the
possibility that ras proteins regulate potassium channels
in a manner similar to that recently demonstrated for
cp2O.
METHODS
Ras protein preparation
H-ras soluble proteins were isolated from Escherichia coli cells essen-
tially as described previously (15). The prokaryotic vector (pJCL-30)
places the ras mutants under the control of the temperature-inducible
lambda pL promoter. 75% purity was first obtained on a AcA54
(molecular sizing) column of the expressed proteins and 90% purity
after a FPLC mono Q column. After dialysis into 50% glycerol, they
were stored at -200 C. Before use, proteins were solubilized in 10 mM
tris, pH 8.0, 5 mM MgC12, and 1 mM EDTA.
Cell isolation and recording
All the experiments were performed on the axotomized type B medial
photoreceptors as previously described (12, 16, 17). Axotomized photo-
receptors were impaled with two intracellular microelectrodes of 15-20
MQ and connected to a 7100 Small-cell Voltage-clamp amplifier
(Pelagic Electronics, Falmouth, MA). The voltage electrode was filled
with either v- or c-ras solution containing (in millimolar) Tris, 10;
MgCl2, 5; EDTA, 1; KCI, 20. 1 M KAc was used as a charge carrier.
The current passing electrode was filled with 3 M KCI, and the
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preparation was bathed in 100mM TEA- artificial sea water, containing
(in millimolar): NaCl, 330; KCI, 10; CaC12 10; MgCl2 50; tris 10 with
osmolarity 990 mOsm at pH 7.4. A high potassium artificial sea water
solution was also employed for calcium current measurements, and
contained (in mM): KCI, 300; NaCl, 35 MgCl2 50; CaC12 10; Tris, 10;
TEA, 100; 4-AP, 5. High external potassium in the bathing medium
made it possible to measure voltage-sensitive calcium currents (Ica2+ ) at
the new equilibrium potential for potassium flux, 0 mV. Command steps
to this level allow maximal activation of the calcium channel, in the
absence of any net potassium flux. Pulse protocols, data acquisition, and
analysis was performed with a computer system (pClamp; Axon
Instruments, Burlingame, CA).
Immediately after impalement, cells were voltage-clamped to -60
mV, and dark adapted for 10 min. Current was sampled at 2 kHz and
leak subtracted on-line using a P/8 protocol. A family of voltage-
activated currents was elicited every 5 min with a series of 10 mV, 1 s
depolarizing steps from -40 to 10 mV, with and without a 500-ms
hyperpolarizing conditioning prepulse to -90 mV. Currents obtained
were in agreement with previous reports for this preparation (12, 16, 17).
A rapidly activating and inactivating outward voltage-dependent cur-
rent peaking at -15 ms and blocked by 4-AP (IA), and a later outward
current, measured at 250 ms and previously characterized as a calcium-
dependent potassium current Ic were initially measured. All the
experiments were carried out in darkness.
Intracellular injections
After stable baseline outward currents were obtained, the recording
condition was switched from the voltage-clamp to the current-clamp
mode and iontophoretic injection of ras was accomplished by applying a
-2 nA constant negative current for 2 min through the voltage
recording electrode. Compensation for the hyperpolarizing effects of the
injection was provided by injecting current of opposite polarity through
the current electrode. Electrodes were loaded with 70 Ag/ml of v-ras or
150 ,g/ml of c-ras. The electrode volume was <10 LI, and we estimate
that the electrode contains -45 x I0 and 21 x 108 c- and v-ras proteins,
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respectively, within 100 um of the tip. An exact measure of the actual
amount of protein injected is not possible with this technique. In a
related study on a central Hermissenda neuron (Collin, C., A. G.
Papageorge, D. Lowy, and D. L. Alkon, manuscript submitted for
publication), pressure injection effects could be compared with the effect
of iontophoretic injection to allow estimation of the number of molecules
necessary for the observed effects. In some experiments, fast green (2
mg/ml) was also added to the ras solution to confirm injection of the
electrode solution into the cell. Buffer alone or heat-inactivated ras (900
C for 2 h) were used as controls. After injections, the recording condition
was switched back to the voltage clamp mode.
RESULTS
Effects of ras injections on IA and Ic
In 100 mM TEA asw it was possible to observe both 'A
and Ic in the absence of the delayed rectifier, which is
minimally activated at membrane potentials .O mV (15).
Current amplitudes and current-to-voltage relationships
were in agreement with data previously reported for this
preparation, and are shown in Fig. 1 and Table 1. No
significant changes of peak amplitudes of either current
were observed immediately after ras injections or inactive
controls. It was possible to keep viable recordings with no
run-down for periods longer than 60 min. 10 min after
v-ras (Fig. 2 A) and 20 min after c-ras injections, small
and progressive reductions Of 'A were observed, without
significant changes of Ic. Reductions of IA by -30-40%,
were clearly significant 30 min after either c- or v-ras
injection (p < 0.002, student's t-test), (Table 1). 40-60%
reductions of Ic developed progressively as well, and
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FIGURE 1 Two electrode voltage clamp recordings from an axotomized medial type B photoreceptor in darkness. (A) Under TEA containing ASW,
cells were held at -60 mV and 10 mV-500 ms steps from -60 to 0 mV were delivered. A voltage dependent, rapidly activating and inactivating
outward current, peaking at - 15 ms and blocked by 4-AP is followed by a later, slowly inactivating outward current that peaks at 200 ms. (B) Current
to voltage relationship is shown for the same cell in A.
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TABLE 1 /A Amplitude at 0 mV (nA). Values are means + SEM
Baseline 10 min 20 min 30 min 60 min
c-ras (N = 5) 44 ± 5 42 ± 3 29 ± 4* 33 ± 4* 46 3
150 ,g/ml
v-ras (N = 5) 46 ± 3 31 ± 2t 27 ± 4* 25 ± 3* 24 3*
70 ,ug/ml
Boiled c- + v-ras 46 ± 3 43 ± 2 45 ± 4 46 ± 5 43 4
150 gg/ml (N = 7)
Buffer alone 44 ± 5 46 ± 3 40 ± 4 45 ± 3 43 5
(N= 5)
Ic Amplitude at 0 mV (nA)
c-ras (N = 5) 13 ± 2 12 ± 1 11 ± 2 6 ± 2* 12 2
150 ,g/ml
v-ras(N= 5) 13 ± 1 13 ± 2 8 ± 1* 8 ± 2* 6 1*
70 Mg/mi
Boiledc- + v-ras 14 ± 2 12 ± 3 14 ± 2 13 ± 2 12 3
150 ,g/ml (N = 7)
Bufferalone 12 ± 4 13 ± 2 12 ± 3 11 ± 3 13 2
(N= 5)
*P < 0.001
tP < 0.002
Peak amplitude of voltage-dependent outward currents measured at different times after injections with c-ras, v-ras, or control solutions. Values are
means ± SD. Statistical significance was assessed comparing each current for a given time interval with its initial baseline level by two tailed t-tests.
became clearly significant 20 min (p < 0.002) after v-ras
injection and 30 min after c-ras injections (Table 1). The
effects were persistent and rather irreversible after v-ras
injection, and only transient, lasting no more than 30 min
after c-ras injection. No changes other than reductions in
conductance were found in the current to voltage relation-
ships of both currents. However, removal of the voltage-
dependent inactivation with hyperpolarizing conditioning
prepulses prevented any c- or v-ras (Fig. 3 A) effects
upon A'S peak amplitude. Removal of voltage-dependent
inactivation did not alter ras injection effects on IC. The
findings prompted us to evaluate A'S inactivation kinetics
after ras injections with a twin pulse protocol, using
variable pulses ranging from -100 to -10 mV and test
pulses of 0 mV. As is shown in Fig. 3 B, 10 min after c- or
v-ras injections, the midpoint of steady state inactivation
was shifted from -55 ± 5 to -70 ± 3 mV, (N = 5). No
effects on the inactivation kinetics were found after heat
inactivated or buffer alone control injections (data not
shown).
sure of IC. 30 min after c-ras injection, ICa2 did not
change, but consistent reductions of 32 ± 7% (n = 5)
were observed for the tail currents. The tail current
reductions recovered spontaneously after 45 min. 20 min
after v-ras injections, the tail currents were reduced by
>46% (N = 4). Ras injections did not alter the light-
induced inward Na2+ current. Heat inactivated c- and v-
ras, or buffer alone injections failed to have any measur-
able effects on either current: ICa2+(nA), 5.0 + 1, and
5.2 ± 1, before and after heat inactivated ras, respec-
tively.
Simultaneous measurements of ICa2+ and Ic were also
performed 30 min after previous addition to the bathing
solution of 10 ,uM of the Protein Kinase C (PKC)
inhibitor Sphingosine. 40 min after ras injections there
were no longer any measurable effects on the K+ tail cur-
rents: tail current amplitude (nA), 33.5 ± 5 and 32.0 + 6,
before and after v-ras injection, respectively.
DISCUSSION
Ras effect on calcium currents
An inward sustained current, blocked by 1 mM Cd2+
similar to the currents previously described in 300 mM
external K+, 5 mM 4-AP, and 100 TEA was elicited with
depolarizing steps to 0 mV (17, 18). A tail current,
carried by reversed potassium flow, also provides a mea-
The two major voltage-dependent K+ currents across the
type B soma membrane, 'A and IC, are shown here to be
targets for v- and c-ras. The only measurable Ca2,
current, a voltage-dependent sustained inward current,
was unaffected by ras injections. The light-induced in-
ward Na+ current was also unaffected. The sequence of
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FIGURE 2 Effects of ras injections on IA and Ic and its time course. (A) Top traces were obtained after injections with 70 Mg/ml of v-ras. 'A reduced
its peak amplitude, but not Ic, which was reduced 10 min later. Changes were sequential and progressive. No recovery was observed at 60 min after
injections. Bottom traces are control injections with heat inactivated c- and v-ras and showed no measurable effects on either current. (B) Percentage
change in IA and Ic after injections of v-ras (N = 5; top) and c-ras (N = 5; bottom) c-ras transiently reduced both lA and Ic (20 and 30 min after
injections, respectively). v-ras effects were faster and irreversible.
potassium current changes after ras injection resembles
the sequence observed with a progressively increased
number of trials during classical conditioning (18). In
both cases, 'A is the first current affected. Ic effects follow
later. This parallel between ras and conditioning-induced
effects raises the possibility that in both cases a common
biochemical pathway is activated. The delay of ras effects,
and the somewhat different nature of the conductance
modifications for both forms of ras are consistent with
involvement of a biochemical regulatory pathway. The
role of phospholipid metabolites as primary targets of ras
during normal or transforming activity is a matter of
controversy, as previously discussed. However, the produc-
tion of intermediaries that can induce mobilization of
intracellular calcium has been ruled out in transformed
cells (3, 9-11). Pathways involving Ca2+-activated pro-
tein phosphorylation, however, could eventually lead to
global modifications of cellular homeostasis during learn-
ing (18, 19), cell growth, and/or oncogenesis, such as the
recently reported down regulation of T calcium channels
in ras-mediated transformed NIH 3T3 cells (20), voltage
sensitive sodium channels in cell-fusion hybrids (21) or
voltage-sensitive calcium channels in BC3H, monocytes
(22). Sustained phospholipid-mediated PKC activation
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FIGURE 3 c-ras changes inactivation kinetics on 'A but not Ic. (A) 20 min after c-ras injections, only 'A showed a 25% reduction of its peak amplitude
when elicited with depolarizing steps to 0 mV from a holding of -60 mV (top traces). With a hyperpolarizing pre-pulse (bottom traces),
c-ras-induced reduction of 'A was eliminated. Ic was unchanged in both conditions. A lower gain display was used because of the overall larger current
amplitudes elicited with this protocol. (B) Voltage dependence of the steady state inactivation of 'A was obtained with a double pulse protocol. A
variable 100-ms prepulse (PI ) from -100 to -10 mV was followed by a 200-ms test pulse to 0 mV (P2). 'A peak amplitude to the P2 was plotted
against P1. 10 min after c-ras injections but not controls, a shift from -55 to -70 mV in the midpoint of inactivation was observed.
may be induced by oncogenic ras (but not proto-
oncogenic ras). Calcium-activated protein phosphoryla-
tion has also been implicated in conditioning-induced
reduction of 'A and Ic (23, 24). A substrate of such
phosphorylation, a 20-21 Kd G-protein, reduces 'A and Ic
(12) as well as regulates axonal transport (13). Therefore,
the function of cp2O during learning may share common
features with ras function in oncogenic contexts.
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